Type 2 DiabetesNCT05687968
Innovative Approaches in Diabetes Care
A study testing Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian in people with Type 2 Diabetes and AI-supported Real-time Dietary Feedback, run by Taipei Medical University at 1 site in Taiwan.
Trial summary
In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Type 2 Diabetes, AI-supported Real-time Dietary Feedback, M-health
- What is being tested?
- Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 39 participants
- Where
- 1 siteTaiwan
- Study dates
- 19 Oct 2022to 1 Oct 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 20 years old or older
- Pre-diabetes or diabetes
- Taiwan nationality or fluent in Mandarin or Taiwanese
- Not pregnant or breastfeeding
- Capable (or assisted by a caregiver) of using a smartphone to photograph and record meals
Who cannot join
- Eating disorders
- Undergoing treatment for severe illnesses that could affect normal dietary intake (e.g., cancer)
- Unable to use a smartphone to take photos and record food intake.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
Jung-Su Chang
Taipei, 110
Jung-Su Chang, PhD, 886-66382736 ext. 6564, susanchang@tmu.edu.tw
About this study
In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. The widespread use of smartphones has facilitated the development of digital health technologies, including digital food photography and artificial intelligence (AI), which show promise for personalized nutrition care and health promotion. While such technologies have demonstrated short-term success in diabetes management, their long-term effectiveness remains uncertain.
This study aims to evaluate the effectiveness of a digital eHealth care intervention for individuals with diabetes. Participants will be recruited from the Diabetes Shared Care Network and community care centers in Taiwan and followed for 12 months. Eligible participants will be randomly assigned by computer to either a control or an eHealth care group.
Read more
- eHealth Group: Receives a 10-minute digital nutrition education session using the lab-developed "3D/AR MetaFood food portion education platform" (https://sketchfab.com/susanlab108/collections) and is required to submit weekly dietary records through food images using the "Formosa FoodAPP." Participants will receive immediate dietary feedback from nutritionists, followed by AI-generated personalized feedback on the glycemic index (GI) and glycemic load (GL) of their meals. They will also be provided with educational videos on healthy eating, physical activity, and selecting low-GI/GL foods.
Anthropometric measurements and baseline questionnaires will be collected at enrollment. Blood biochemistry, including HbA1c, will be measured at baseline, and at 3, 6, 9, and 12 months. Collected food image data will be used to train AI systems for real-time dietary feedback and to explore the relationship between nutrient intake and long-term glycemic control.
Read the detailed description
Objective:
This study aims to evaluate the effectiveness of eHealth interventions in the care of patients with diabetes.
Study Design:
Adult participants with diabetes will be recruited from the Diabetes Shared Care Network and community centers for a 12-month intervention study.
Eligibility Criteria:
Participants must be aged 20 years or older, diagnosed with prediabetes or diabetes, of Taiwanese nationality or fluent in Mandarin or Taiwanese, not pregnant or breastfeeding, and capable (or assisted by a caregiver) of using a smartphone to photograph and record meals. Individuals with diagnosed eating disorders will be excluded.
Intervention Arms
- eHealth Group: Participants will receive 10 minutes of portion size and nutrition education using the lab-developed "MetaFood: 3D/AR Digital Food Education Platform" (https://sketchfab.com/susanlab108/collections). They are required to submit a food image-based dietary record once per week using the lab-developed "Formosa FoodAPP" (1). Trained nutritionists will assess the dietary images using a lab-developed "Digital Photographic Food Atlas" and provide real-time dietary feedback via a LINE social group.
Additionally, the eHealth group will receive educational materials including videos and digital leaflets on:
- How to use the Formosa FoodAPP
- Introduction to MyPlate: food classification and portion sizes
- The impact of food on blood glucose: understanding glycemic index (GI) and glycemic load (GL)
- GI/GL values of commonly consumed Taiwanese foods
- Interpretation of blood test reports
- Making food choices when dining out
- Basics of exercise
- Eating during festivals
From the 5th month onward, personalized dietary feedback on the GI/GL values of consumed meals will be provided by lab-developed AI systems, continuing until the end of the study. AI systems for food recognition and the LINE group are managed by lab staff.
Biological Measures:
Fasting blood glucose and lipid profiles will be collected every three months during clinic visits.
Sample Size Justification:
Using G*Power 3.1.9.7, the primary endpoint is the effect of AI-supported dietary feedback on glycemic control in middle-aged and older adults with type 2 diabetes. Based on Lee et al.'s study on the combination of human and AI-supported nutrition app, the estimated mean HbA1c difference is 0.52% (7.52±0.81 vs. 7.00±0.66) at 12 months. Assuming an effect size of 0.70, 80% power, and 5% significance, 33 participants per group are needed. Accounting for a 10-20% attrition rate, a total sample of 36-40 participants will be recruited.
Data Collection:
Baseline sociodemographic and anthropometric data will be collected by state-registered dietitians. Standard biochemical test results, available from Taiwan's National Health Insurance, will be collected every three months. Nutrition knowledge, and perceptions and usage of digital food technologies, will be assessed via an online questionnaire developed from the theoretical framework, literature review, and validated by experts. Weekly dietary records will be logged via the Formosa FoodAPP (1).
Data will include:
- Demographics: Age, sex, education level, disease history
- Weekly dietary records
- Anthropometrics: Height, weight, BMI, waist circumference, grip strength, muscle strength
- Biochemical data: Fasting glucose, lipid profiles, renal function indicators (clinic-based, insurance-covered tests)
Statistical Analysis:
Data will be analyzed using GraphPad Prism 5 (La Jolla, CA, USA).
- Normality: Kolmogorov-Smirnov test
- Continuous variables: Mean ± 95% CI; analyzed via t-tests or ANOVA
- Categorical variables: Frequencies/percentages; analyzed via Chi-square or Fisher's exact test
- Correlations: Spearman's coefficient; logistic linear regression
- Nonparametric comparisons: Kruskal-Wallis test
- Longitudinal analysis: Generalized Linear Mixed Model (GLMM) for glycemic changes and comorbidity risks
- Significance threshold: p < 0.05
- Being tested
- Real-Time Personalized Dietary Feedback (via AI and Nutritionist), conventional nutrition education by dietitian
- Keywords
- Diabetes Mellitus, AI-supported real-time dietary feedback, M-health
- Medical subject headings
- Diabetes Mellitus, Type 2, Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Real-Time Personalized Dietary Feedback (via AI and Nutritionist)Behavioural
- Behavioral: "3D/AR MetaFood" Portion Size and Nutrition Education
- Behavioral: Nutrition and Physical Activity Educational Videos
conventional nutrition education by dietitianBehavioural
The participants receive conventional health and nutrition education from state registered dietitian.
| Study group | Role | What they receive |
|---|---|---|
| eHealth group | Experimental | Participants in the eHealth group will receive a multi-component digital health intervention. This includes:
1. Real-time personalized dietary feedback based on weekly food image submissions via the Formosa FoodAPP, delivered initially by trained nutritionists and later by AI.
2. A 10-minute digital food portion size and nutrition education session using the lab-developed "3D/AR MetaFood" platform.
3. Access to educational videos on healthy eating, glycemic index/load, physical activity, and digital food recording. Receives: Behavioral: Real-Time Personalized Dietary Feedback (via AI and Nutritionist); Behavioral: conventional nutrition education by dietitian |
What is being measured
The primary outcome is the main question the study is designed to answer.
HbA1c
the change of HbA1c
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Fasting glucose
the change of Fasting glucose
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Secondary outcomes (23)
Triglyceride (TG)
the change of Triglyceride (TG)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Total cholesterol (TC)
the change of total cholesterol (TC)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Low-density lipoprotein-cholesterol (LDL-C)
the change of low-density lipoprotein-cholesterol (LDL-C)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Triglyceride-glucose (TyG)
the change of triglyceride-glucose (TyG)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Estimated Glomerular filtration rate (eGFR)
the change of estimated Glomerular filtration rate (eGFR)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Creatinine (CRE)
the change of creatinine (CRE)
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Food portion)
the change of food portion
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Energy)
the change of Energy
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Carbohydrate)
the change of Carbohydrate
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Fiber)
the change of Fiber
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Sugar)
the change of Sugar
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Protein)
the change of Protein
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Fat)
the change of Fat
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Saturated Fat)
the change of Saturated Fat
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Cholesterol)
the change of Cholesterol
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Sodium)
the change of Sodium
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Potassium)
the change of Potassium
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Calcium)
the change of Calcium
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Magnesium)
the change of Magnesium
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Iron)
the change of Iron
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Vitamin C)
the change of Vitamin C
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Dietary GI)
the change of Dietary GI
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Dietary GL)
the change of Dietary GL
Measured: baseline, 3 month, 6 month, 9 month, 12 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2023
- Study start19 Oct 2022
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Type 2 DiabetesStudies of the same condition, open and under way.
- More trials run by Taipei Medical UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 39 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Taipei Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jung-Su Chang, PhD., Principal investigator, College of Nutrition, Taipei Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05687968
- Sponsor's protocol ID
- N202101052
- Status last verified
- Jun 2025
- First submitted
- 9 Jan 2023
- Last updated
- 30 Jul 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Ho DKN, Chiu WC, Kao JW, Tseng HT, Yao CY, Su HY, Wei PH, Le NQK, Nguyen HT, Chang JS. Mitigating errors in mobile-based dietary assessments: Effects of a data modification process on the validity of an image-assisted food and nutrition app. Nutrition. 2023 Dec;116:112212. doi: 10.1016/j.nut.2023.112212. Epub 2023 Sep 9.
PubMed 37776838Lee YB, Kim G, Jun JE, Park H, Lee WJ, Hwang YC, Kim JH. An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes Care. 2023 May 1;46(5):959-966. doi: 10.2337/dc22-1929.
PubMed 36821833
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Innovative Approaches in Diabetes Care
- ClinicalTrials.gov ID
- NCT05687968
- Acronym / sponsor ID
- N202101052
- Keywords
- Diabetes Mellitus, AI-supported real-time dietary feedback, M-health
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 39 participants (estimated)
- Lead sponsor
- Taipei Medical UniversityUniversity, hospital or other
- Study start
- 19 Oct 2022 (actual)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Oct 2025 (estimated)
- First posted
- 18 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In Taiwan, an estimated 2.3 million individuals have diabetes, with a 44% increase observed among young adults and adolescents. Poor dietary habits and sedentary lifestyles are major risk factors for type 2 diabetes. The widespread use of smartphones has facilitated the development of digital health technologies, including digital food photography and artificial intelligence (AI), which show promise for personalized nutrition care and health promotion. While such technologies have demonstrated short-term success in diabetes management, their long-term effectiveness remains uncertain.
This study aims to evaluate the effectiveness of a digital eHealth care intervention for individuals with diabetes. Participants will be recruited from the Diabetes Shared Care Network and community care centers in Taiwan and followed for 12 months. Eligible participants will be randomly assigned by computer to either a control or an eHealth care group.
- eHealth Group: Receives a 10-minute digital nutrition education session using the lab-developed "3D/AR MetaFood food portion education platform" (https://sketchfab.com/susanlab108/collections) and is required to submit weekly dietary records through food images using the "Formosa FoodAPP." Participants will receive immediate dietary feedback from nutritionists, followed by AI-generated personalized feedback on the glycemic index (GI) and glycemic load (GL) of their meals. They will also be provided with educational videos on healthy eating, physical activity, and selecting low-GI/GL foods.
Anthropometric measurements and baseline questionnaires will be collected at enrollment. Blood biochemistry, including HbA1c, will be measured at baseline, and at 3, 6, 9, and 12 months. Collected food image data will be used to train AI systems for real-time dietary feedback and to explore the relationship between nutrient intake and long-term glycemic control.
Detailed description
Objective:
This study aims to evaluate the effectiveness of eHealth interventions in the care of patients with diabetes.
Study Design:
Adult participants with diabetes will be recruited from the Diabetes Shared Care Network and community centers for a 12-month intervention study.
Eligibility Criteria:
Participants must be aged 20 years or older, diagnosed with prediabetes or diabetes, of Taiwanese nationality or fluent in Mandarin or Taiwanese, not pregnant or breastfeeding, and capable (or assisted by a caregiver) of using a smartphone to photograph and record meals. Individuals with diagnosed eating disorders will be excluded.
Intervention Arms
- eHealth Group: Participants will receive 10 minutes of portion size and nutrition education using the lab-developed "MetaFood: 3D/AR Digital Food Education Platform" (https://sketchfab.com/susanlab108/collections). They are required to submit a food image-based dietary record once per week using the lab-developed "Formosa FoodAPP" (1). Trained nutritionists will assess the dietary images using a lab-developed "Digital Photographic Food Atlas" and provide real-time dietary feedback via a LINE social group.
Additionally, the eHealth group will receive educational materials including videos and digital leaflets on:
- How to use the Formosa FoodAPP
- Introduction to MyPlate: food classification and portion sizes
- The impact of food on blood glucose: understanding glycemic index (GI) and glycemic load (GL)
- GI/GL values of commonly consumed Taiwanese foods
- Interpretation of blood test reports
- Making food choices when dining out
- Basics of exercise
- Eating during festivals
From the 5th month onward, personalized dietary feedback on the GI/GL values of consumed meals will be provided by lab-developed AI systems, continuing until the end of the study. AI systems for food recognition and the LINE group are managed by lab staff.
Biological Measures:
Fasting blood glucose and lipid profiles will be collected every three months during clinic visits.
Sample Size Justification:
Using G*Power 3.1.9.7, the primary endpoint is the effect of AI-supported dietary feedback on glycemic control in middle-aged and older adults with type 2 diabetes. Based on Lee et al.'s study on the combination of human and AI-supported nutrition app, the estimated mean HbA1c difference is 0.52% (7.52±0.81 vs. 7.00±0.66) at 12 months. Assuming an effect size of 0.70, 80% power, and 5% significance, 33 participants per group are needed. Accounting for a 10-20% attrition rate, a total sample of 36-40 participants will be recruited.
Data Collection:
Baseline sociodemographic and anthropometric data will be collected by state-registered dietitians. Standard biochemical test results, available from Taiwan's National Health Insurance, will be collected every three months. Nutrition knowledge, and perceptions and usage of digital food technologies, will be assessed via an online questionnaire developed from the theoretical framework, literature review, and validated by experts. Weekly dietary records will be logged via the Formosa FoodAPP (1).
Data will include:
- Demographics: Age, sex, education level, disease history
- Weekly dietary records
- Anthropometrics: Height, weight, BMI, waist circumference, grip strength, muscle strength
- Biochemical data: Fasting glucose, lipid profiles, renal function indicators (clinic-based, insurance-covered tests)
Statistical Analysis:
Data will be analyzed using GraphPad Prism 5 (La Jolla, CA, USA).
- Normality: Kolmogorov-Smirnov test
- Continuous variables: Mean ± 95% CI; analyzed via t-tests or ANOVA
- Categorical variables: Frequencies/percentages; analyzed via Chi-square or Fisher's exact test
- Correlations: Spearman's coefficient; logistic linear regression
- Nonparametric comparisons: Kruskal-Wallis test
- Longitudinal analysis: Generalized Linear Mixed Model (GLMM) for glycemic changes and comorbidity risks
- Significance threshold: p < 0.05
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| eHealth group | Experimental | Behavioral: Real-Time Personalized Dietary Feedback (via AI and Nutritionist), Behavioral: conventional nutrition education by dietitianParticipants in the eHealth group will receive a multi-component digital health intervention. This includes: 1. Real-time personalized dietary feedback based on weekly food image submissions via the Formosa FoodAPP, delivered initially by trained nutritionists and later by AI. 2. A 10-minute digital food portion size and nutrition education session using the lab-developed "3D/AR MetaFood" platform. 3. Access to educational videos on healthy eating, glycemic index/load, physical activity, and digital food recording. |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- 20 years old or older
- Pre-diabetes or diabetes
- Taiwan nationality or fluent in Mandarin or Taiwanese
- Not pregnant or breastfeeding
- Capable (or assisted by a caregiver) of using a smartphone to photograph and record meals
Key exclusion criteria (3 listed)
- Eating disorders
- Undergoing treatment for severe illnesses that could affect normal dietary intake (e.g., cancer)
- Unable to use a smartphone to take photos and record food intake.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Real-Time Personalized Dietary Feedback (via AI and Nutritionist)* Behavioral: "3D/AR MetaFood" Portion Size and Nutrition Education * Behavioral: Nutrition and Physical Activity Educational Videos | Behavioural | eHealth group |
| conventional nutrition education by dietitianThe participants receive conventional health and nutrition education from state registered dietitian. | Behavioural | eHealth group |
Primary outcome
HbA1c
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
the change of HbA1c
Fasting glucose
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
the change of Fasting glucose
23 secondary outcomes
Triglyceride (TG)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Total cholesterol (TC)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Low-density lipoprotein-cholesterol (LDL-C)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Triglyceride-glucose (TyG)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Estimated Glomerular filtration rate (eGFR)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Creatinine (CRE)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Food portion)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Energy)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Carbohydrate)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Fiber)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Sugar)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Protein)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Fat)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Saturated Fat)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Cholesterol)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Sodium)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Potassium)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Calcium)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Magnesium)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Iron)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Vitamin C)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Dietary GI)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Dietary Intake (Dietary GL)
Time frame: baseline, 3 month, 6 month, 9 month, 12 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2025.
- Background: PubMed 37776838Ho DKN, Chiu WC, Kao JW, Tseng HT, Yao CY, Su HY, Wei PH, Le NQK, Nguyen HT, Chang JS. Mitigating errors in mobile-based dietary assessments: Effects of a data modification process on the validity of an image-assisted food and nutrition app. Nutrition. 2023 Dec;116:112212. doi: 10.1016/j.nut.2023.112212. Epub 2023 Sep 9.
- Background: PubMed 36821833Lee YB, Kim G, Jun JE, Park H, Lee WJ, Hwang YC, Kim JH. An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial. Diabetes Care. 2023 May 1;46(5):959-966. doi: 10.2337/dc22-1929.
- Individual participant dataSharing planned: No
Related trials for Type 2 Diabetes
Active, not recruitingPhase 2
A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease
Diabetic Kidney Disease (DKD), Type 2 Diabetes
Recruiting
Culturally Tailored Program for Food-Insecure Adults: SPICE-D
Type 2 Diabetes Mellitus (T2D)
Not yet recruiting
Evaluation of the Effectiveness of Implementing a Screening Strategy for the Diagnosis of Prediabetes and Type 2 Diabetes Mellitus in Primary Health Care in a Brazilian Municipality
Diabetes Mellitus (Type 2), Prediabetes
Active, not recruitingPhase 1/2
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
Not yet recruiting
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
Type 2 Diabetes (T2DM), Endothelial Dysfunction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jung-Su Chang, PhD. principal investigator
College of Nutrition, Taipei Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Real-Time Personalized Dietary Feedback (via AI and Nutritionist) and conventional nutrition education by dietitian in people with Type 2 Diabetes and AI-supported Real-time Dietary Feedback, run by Taipei Medical University at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jung-Su Chang, PhD. (886-66382736 ext. 6506, susanchang@tmu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
HbA1c (time frame: baseline, 3 month, 6 month, 9 month, 12 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05687968, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.